Average Co-Inventor Count = 7.17
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vtv Therapeutics LLC (21 from 52 patents)
2. Transtech Pharma, Inc. (13 from 49 patents)
3. Novo Nordisk A/s (10 from 1,777 patents)
4. High Point Pharmaceuticals, LLC (8 from 50 patents)
52 patents:
1. 12091407 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
2. 11970457 - Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-phenoxy)-propyl]-diethyl-amine
3. 11649230 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
4. 11524942 - Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-phenoxy)-propyl]-diethyl-amine
5. 11130753 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
6. 10889580 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
7. 10570126 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
8. 10568888 - Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
9. 10391097 - Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
10. 10364233 - Piperidine derivative and methods of use thereof
11. 10287284 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
12. 10085990 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
13. 10030011 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
14. 9833457 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
15. 9687489 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors